Growth Capital For Life Sciences & Healthcare
Telegraph Hill Partners is a venture capital firm dedicated to helping life science, medical device and healthcare companies achieve their growth objectives. When you work with us, you get an experienced team that knows how to drive growth and profitability while maintaining the vision and integrity of the organization.
We seek to partner with innovative companies by providing capital and strategic guidance to help them grow.
Latest News & Announcements
PerkinElmer Invests in Carterra, the Leader in Label-Free High Throughput Antibody Screening and Characterization
Carterra, Inc., the world leader in label-free high throughput antibody screening and characterization, today announced that they have closed on a round of equity financing led by PerkinElmer, Inc. Current Carterra investors Telegraph Hill Partners and Ballast Point Ventures also participated in the [...]
Specific Diagnostics Announces Designation as an ISO-13485-Compliant Medical Device Manufacturer
December 2, 2020 - MOUNTAIN VIEW, California – FOR IMMEDIATE RELEASE Specific Diagnostics today announced that it has received ISO-13485 certification through the International Organization for Standardization. A QMS conforming to ISO-13485 meets the highest FDA standards applicable to the manufact [...]
Agena Bioscience Granted EUA for High-Throughput, Low-Cost SARS-CoV-2 Panel
Agena Bioscience®, a global provider of low-cost and high-throughput molecular testing solutions, today announced that its MassARRAY® SARS-CoV-2 Panel for qualitative detection of the SARS-CoV-2 coronavirus has been granted Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) [...]